Zivo Bioscience, Inc.
Extracted from this filing and checked against the source text.
Zivo Bioscience, Inc. shareholders approved Election of one director to serve a three-year term until the 2026 annual meeting of stockholders at the 2023-06-12 meeting.
Proposal 1—Election of Directors Nominee Votes For Votes Withheld Broker Non-Votes Christopher D. Maggiore 3,050,053 393,297 2,704,419View on SEC.gov
Zivo Bioscience, Inc. shareholders approved Approval (on an advisory basis) of the compensation of the Company's named executive officers at the 2023-06-12 meeting.
Proposal 3 — Approval (on an advisory basis) of the compensation of the Company's named executive officers Votes For Votes Against Votes Abstain 3,252,348 186,946 4,056View on SEC.gov
Zivo Bioscience, Inc. shareholders approved Ratification of the appointment of BDO USA, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-12 meeting.
Proposal 2—Ratification of Appointment of Independent Registered Public Accounting Firm Votes For Votes Against Votes Abstain 5,982,232 164,958 579View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.